Syndax Pharmaceuticals In... (SNDX)
14.21
-0.03 (-0.21%)
At close: Jan 30, 2025, 3:59 PM
14.21
0.00%
After-hours Jan 30, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -7.25 | -10.76 | 45.72 | -12.57 | -4.78 | -1.53 | -3.03 | -2.36 | -8.64 | -5.81 | -6.78 | -84.64 | -0.57 |
| PS Ratio | n/a | n/a | 8.16 | 605.60 | 176.47 | 74.43 | 87.26 | 85.92 | 332.49 | n/a | n/a | n/a | n/a |
| PB Ratio | 2.74 | 3.31 | 2.79 | 3.64 | 8.47 | 2.13 | 1.76 | 1.25 | 3.13 | -20.15 | 8.11 | -28.8 | -0.39 |
| P/FCF Ratio | -9.45 | -11.55 | 39.30 | -12.89 | -5.29 | -1.64 | -3.88 | -2.96 | -84.16 | -8 | -13.1 | -90.74 | -0.74 |
| P/OCF Ratio | -9.45 | -11.57 | 39.12 | -12.89 | -5.29 | -1.65 | -3.88 | -2.98 | -85.86 | -8 | -13.17 | -90.85 | -0.74 |
| OCF/S Ratio | n/a | n/a | 0.21 | -46.97 | -33.36 | -45.18 | -22.47 | -28.82 | -3.87 | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.05 | 0.08 | 0.03 | n/a | n/a | n/a | n/a | -2.43 | n/a | -0.73 | -1.02 |
| Quick Ratio | 10.00 | 16.70 | 21.31 | 15.56 | 3.30 | 5.11 | 8.54 | 10.24 | 18.10 | 1.20 | 5.33 | 0.03 | 0.33 |
| Current Ratio | 10.00 | 16.56 | 21.68 | 15.84 | 3.39 | 5.18 | 8.45 | 10.47 | 18.16 | 1.20 | 5.33 | 0.03 | 0.33 |
| Asset Turnover | n/a | n/a | 0.31 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | n/a | n/a | n/a | n/a |
| Interest Coverage | -1.11K | -48.38 | 13.81 | -30.3 | -36.63 | -39.07 | -43.6 | -45.78 | -13.02 | n/a | n/a | n/a | -4.85 |
| Return on Equity (ROE) | -0.38 | -0.31 | 0.06 | -0.29 | -1.77 | -1.39 | -0.58 | -0.53 | -0.36 | 3.47 | -1.2 | 0.34 | 0.69 |
| Return on Assets (ROA) | -0.34 | -0.29 | 0.06 | -0.24 | -0.88 | -0.88 | -0.44 | -0.41 | -0.27 | -1.55 | -0.83 | -6.6 | -2.73 |
| Return on Capital (ROIC) | -0.41 | -0.32 | 0.06 | -0.25 | -1.27 | -1.12 | -0.51 | -0.44 | -0.24 | -8.64 | -0.6 | 0.37 | 1.12 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.02 | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.06 | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | 99.67% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | 17.84% | -4.82K% | -3.69K% | -4.88K% | -2.88K% | -3.65K% | -3.85K% | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | 17.84% | -4.82K% | -3.69K% | -4.88K% | -2.88K% | -3.65K% | -3.85K% | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | 18.77% | -4.71K% | -3.79K% | -5.00K% | -2.94K% | -3.59K% | -3.27K% | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | 20.76% | -4.70K% | -3.34K% | -4.53K% | -2.25K% | -2.90K% | -395.06% | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | 19.53% | -4.63K% | -3.66K% | -4.87K% | -2.94K% | -3.58K% | -3.27K% | n/a | n/a | n/a | n/a |